|
| | 09800HB0702sam001 | - 2 - | LRB098 03526 JDS 44928 a |
|
|
1 | | medical or pathological laboratories; cultures and stocks |
2 | | of infectious
agents from research and industrial |
3 | | laboratories; wastes from the
production of biologicals; |
4 | | discarded live or attenuated vaccines; or
culture dishes |
5 | | and devices used to transfer, inoculate, or mix cultures.
|
6 | | (2) Human pathological wastes. This waste shall |
7 | | include tissue, organs,
and body parts (except teeth and |
8 | | the contiguous
structures of bone and gum); body fluids |
9 | | that are removed during surgery,
autopsy, or other medical |
10 | | procedures; or specimens of body fluids and their
|
11 | | containers.
|
12 | | (3) Human blood and blood products. This waste shall |
13 | | include discarded
human blood, blood components (e.g., |
14 | | serum and plasma), or saturated material
containing free |
15 | | flowing blood or blood components.
|
16 | | (4) Used sharps. This waste shall include but not be |
17 | | limited to
discarded sharps used in animal or human patient |
18 | | care, medical
research, or clinical or pharmaceutical |
19 | | laboratories; hypodermic,
intravenous, or other medical
|
20 | | needles; hypodermic or intravenous syringes; Pasteur |
21 | | pipettes; scalpel
blades; or blood vials. This waste shall |
22 | | also include but not be limited
to other types of broken or |
23 | | unbroken glass (including slides and cover
slips) in |
24 | | contact with infectious agents.
|
25 | | (5) Animal waste. Animal waste means discarded |
26 | | materials, including
carcasses, body parts, body fluids, |
|
| | 09800HB0702sam001 | - 3 - | LRB098 03526 JDS 44928 a |
|
|
1 | | blood, or bedding originating from animals
inoculated |
2 | | during research, production of biologicals, or |
3 | | pharmaceutical
testing with agents infectious to humans.
|
4 | | (6) Isolation waste. This waste shall include |
5 | | discarded materials
contaminated with blood, excretions, |
6 | | exudates, and secretions from humans
that are isolated to |
7 | | protect others from highly communicable diseases.
"Highly |
8 | | communicable diseases" means those diseases identified by |
9 | | the Board
in rules adopted under subsection (e) of Section |
10 | | 56.2 of this Act.
|
11 | | (7) Unused sharps. This waste shall include but not be |
12 | | limited to the
following unused, discarded sharps: |
13 | | hypodermic, intravenous, or
other needles; hypodermic or |
14 | | intravenous syringes; or scalpel blades.
|
15 | | (b) Potentially infectious medical waste does not include:
|
16 | | (1) waste generated as general household waste;
|
17 | | (2) waste (except for sharps) for which the infectious |
18 | | potential has
been eliminated by treatment; or
|
19 | | (3) sharps that meet both of the following conditions:
|
20 | | (A) the infectious potential has been eliminated |
21 | | from the sharps by
treatment; and
|
22 | | (B) the sharps are rendered unrecognizable by |
23 | | treatment ; or .
|
24 | | (4) sharps that are managed in accordance with the |
25 | | following requirements: |
26 | | (A) the infectious potential is eliminated from |
|
| | 09800HB0702sam001 | - 4 - | LRB098 03526 JDS 44928 a |
|
|
1 | | the sharps by treatment at a facility that is permitted |
2 | | by the Agency for the treatment of potentially |
3 | | infectious medical waste; |
4 | | (B) the sharps are certified by the treatment |
5 | | facility as non-special waste in accordance with |
6 | | Section 22.48 of this Act; |
7 | | (C) the sharps are packaged at the treatment |
8 | | facility the same as required under Board rules for |
9 | | potentially infectious medical waste; |
10 | | (D) the sharps are transported under the custody of |
11 | | the treatment facility to a landfill permitted by the |
12 | | Agency under Section 21 of this Act to accept municipal |
13 | | waste for disposal; and |
14 | | (E) the activities in subparagraphs (A) through |
15 | | (D) of this paragraph (4) are authorized in, and |
16 | | conducted in accordance with, a permit issued by the |
17 | | Agency to the treatment facility. |
18 | | (Source: P.A. 92-574, eff. 6-26-02.)".
|